Skip to main content
. 2014 Dec 25;38(1):87–100. doi: 10.1007/s40264-014-0251-y

Fig. 9.

Fig. 9

Proportion of relevant and unlabeled drug–event pairs classified as ‘Merits further evaluation.’ Each pie chart represents one of the six assessors